“…excellent legal work and value…”

Sean H. Mallean
President & CEO
Axeus, Inc

Johnson Fistel is currently investigating a number of publicly traded companies for allegedly violating state and federal laws, some of which are already named as a defendant in a securities fraud class action.

Pending Class Actions

For more information about existing securities fraud class actions, including upcoming important deadlines, please click here.

Investigations

For more information about ongoing investigations, please click on the name of the company below.

VinFast Auto Ltd.

VinFast Class Action Lawsuit News – Seek Counsel Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP (VFS) Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of VinFast Auto Ltd. (NASDAQ: VFS) (“VinFast ” or the “Company”). Join the VinFast class action lawsuit to potentially recover losses. Johnson Fistel LLP, a top law firm, can help you become the lead plaintiff. Stay updated on the lawsuit by checking for the latest news. The class action is on behalf of shareholders who purchased or otherwise acquired securities between August 15, 2023 and January 17, 2024. Investors have until June 11, 2024, to move the Court to serve as lead plaintiff in this action. The complaint alleges that, throughout the Class Period, including in the Offering Documents for the Merger with Black Spade, the defendants misrepresented and/or failed to disclose that: (i)

Zoetis Inc.

Investigation into Zoetis Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Zoetis securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Zoetis securities? If you believe that you may have a potential claim against Zoetis and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471 or click here to join the investigation online. There is no cost or obligation to

Globe Life Inc.

Investigation into Globe Life Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Globe Life Inc. (“Globe Life” or “the Company”) (NYSE: GL). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Globe Life Life securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Globe Life securities? If you believe that you may have a potential claim against Globe Life and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online.

DocGo Inc.

Investigation into DocGo Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by DocGo Inc. (“DocGo” or “the Company”) (NASDAQ: DCGO). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased DocGo securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased DocGo securities? If you believe that you may have a potential claim against DocGo and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online. There is no cost or obligation to

iRhythm Technologies, Inc.

Investigation Alert iRhythm Technologies: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of iRhythm Technologies, Inc. against certain of its officers and directors. If you have continuously owned iRhythm shares before January 11, 2022, you can click or copy and paste the link below in a browser to join this action: Recently a class action lawsuit was filed against iRhythm. According to the lawsuit, defendants falsely represented to investors that one of iRhythm’s main products, the Zio AT monitor, was a real-time heart monitor intended for high-risk patients. Specifically, defendants repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients. As a result of these misrepresentations,

Xponential Fitness, Inc.

Investigation Alert Xponential Fitness: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of Xponential Fitness, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Xponential Fitness, Inc. (NYSE: XPOF) against certain of its officers and directors. If you are a current, long-term shareholder of Xponential Fitness holding shares before July 26, 2021, you can click or copy and paste the link below in a browser to join this action: Recently a class action lawsuit was filed against Xponential Fitness. The filed complaint alleges that defendants made false statements and/or concealed that: (a) Xponential had permanently closed at least 30 stores; (b) Xponential’s reported  same-store sales (“SSS”) and average unit volume metrics had been misstated by excluding underperforming stores; (c) 8 out of 10 Xponential brands were losing

Hut 8 Corp.

Investigation Alert Hut 8: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of Hut 8 Corp. (NASDAQ: HUT). If you have continuously owned Hut 8 Corp., shares since before November 9, 2023, submit your information below: Recently a class action lawsuit was filed against the company. Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants failed to disclose to investors: (1) that one of USBTC’s largest shareholders is an undisclosed related party; (2) that USBTC’s core asset has historically failed to provide energy and high-speed internet; (3) that the profitability of certain USBTC assets were overstated; and (4) that, as a result of the foregoing, Defendants’ positive statements about

Amylyx Pharmaceuticals, Inc.

Investigation Amylyx Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of Amylyx Pharmaceuticals, Inc against certain of its officers and directors. If you are a current, long-term shareholder of Amylyx holding shares before November 11, 2022, you may have standing to hold Amylyx harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action: Recently a class action lawsuit was filed against the company. The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose

AXT, Inc.

Investigation into AXT Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased AXT securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased AXT securities? If you believe that you may have a potential claim against AXT and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online. There is no cost or obligation to

Dayforce, Inc.

Investigation into Dayforce Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Dayforce, Inc. (“Dayforce” or the “Company”) (NYSE: DAY). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Dayforce securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Dayforce securities? If you believe that you may have a potential claim against Dayforce and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online. There is no cost or obligation to

Lamb Weston Holdings, Inc.

Investigation into Lamb Weston Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Lamb Weston Holdings, Inc. (NYSE: LW) (“Lamb Weston” or “the Company”). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Lamb Weston securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Lamb Weston securities? If you believe that you may have a potential claim against Lamb Weston and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online.

Exscientia plc

Investigation into Exscientia Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations – What Shareholders Need to Know! Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Exscientia plc (NASDAQ: EXAI) (“Exscientia” or “the Company”). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Exscientia securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Exscientia securities? If you believe that you may have a potential claim against Exscientia and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or click here to join the investigation online. There is no cost or obligation to

Endeavor Group Holdings, Inc.

Endeavor News: Top Stockholder Rights Firm Investigates Endeavor’s $27.50 Per Share Sale to Silver Lake: Contact Johnson Fistel For More Information Johnson Fistel, LLP, a leading stockholder rights law firm, announced today that it has initiated an investigation into the board members of Endeavor Group Holdings, Inc. (NYSE: EDR) (“Endeavor”) concerning potential breaches of fiduciary duties related to the proposed sale of the Company to Silver Lake. On April 2, 2024, Endeavor informed the public that it has agreed to a deal with Silver Lake, in which stockholders will receive $27.50 per share in an all-cash offer. Upon completion of the deal, Endeavour will be a private Company. The transaction will be financed through a combination of new and reinvested equity from Silver Lake and additional capital from several sources including equity rolled over by members of the Endeavor management team. Johnson Fistel’s investigation focuses on whether Endeavor’s board failed

Cummins Inc.

Cummins, Inc. Long-Term Shareholder Announcement: Johnson Fistel, LLP Encourages Investors to Reach Out For More Information Johnson Fistel, LLP is investigating potential claims on behalf of Cummins Inc. (NYSE: CMI) against certain of its officers and directors to hold them responsible for damages they allegedly caused the company to suffer. If you have continuously owned Cummins Inc. (NYSE: CMI) shares, you have certain legal rights as a shareholder.  If you want to learn more, please read below or submit your information at: On December 22, 2023, Cummins reached an agreement with the U.S. Department of Justice, the U.S. Environmental Protection Agency (EPA), and the State of California to settle allegations related to emissions violations. The company agreed to pay a substantial $1.675 billion civil penalty for its actions. California Attorney General Rob Bonta emphasized that Cummins knowingly evaded state emissions tests and requirements, causing harm to public health and the environment. This

Direct Digital Holdings, Inc.

Direct Digital Holdings Alert – Johnson Fistel, LLP Encourages Shareholders to Contact the Firm Following the DRCT Earnings Report Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Direct Digital Holdings, Inc. (NASDAQ: DRCT). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Direct Digital Holdings securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. What if I purchased Direct Digital Holdings securities? If you believe that you may have a potential claim against Direct Digital Holdings and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471) or join the investigation below. There is no cost or obligation

SSR Mining, Inc.

SSRM NEWS: Johnson Fistel Encourages SSR Mining Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline The Denver office of Shareholder rights law firm Johnson Fistel, LLP, announces that a class action lawsuit has commenced on behalf of investors of SSR Mining, Inc. (NASDAQ: SSRM), a Denver headquartered company. The class action is on behalf of shareholders who purchased or otherwise acquired stock between February 23, 2022 and February 27, 2024 (the “Class Period”). Investors are hereby notified that they have until May 17, 2024, to move the Court to serve as lead plaintiff in this action. On February 13, 2024, when SSR Mining stock fell 46% following a report that the Company halted all operations at its Copler gold mine in Turkey due to “a large slip on the heap leach pad”. Nine miners were missing; the Turkish government said it has launched an investigation into the incident. Then on

Alaska Air Group, Inc.

Alaska Air Announcement: Johnson Fistel, LLP Encourages Investors to Reach Out For More Information Regarding Investigation Johnson Fistel, LLP is investigating potential claims on behalf of Alaska Air Group, Inc. (“Alaska Air”) (NYSE: ALK) against certain of its officers and directors to hold them responsible for damages they allegedly caused the company to suffer. If you have continuously owned Alaska Air shares since before January 2024 you have certain legal rights as a shareholder.  If you want to learn more, please read below or submit your information at: On January 6, 2024, a Boeing 737 MAX 9 aircraft operated by Alaska Airlines made an emergency landing after a door plug manufactured by Spirit AeroSystems blew off shortly after takeoff.  All Boeing 737 MAX 9 aircraft were subsequently grounded for safety reasons.  If you would like to know more about your rights as a shareholder or how you can participate in holding the

Lifecore Biomedical, Inc.

Lifecore Alert: Johnson Fistel, LLP Investigates Claims on Behalf of Investors – LFCR Shareholder rights law firm Johnson Fistel, LLP is investigating whether Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Lifecore securities? If you bought securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you. What is Johnson Fistel investigating? On March 20, 2024, Lifecore issued its Annual Report on Form 10-K/A for the year ended May 29, 2022, the Company’s unaudited consolidated financial statements as of and for the periods ending August

Sonder Holdings Inc.

Sonder Holdings Alert: Class Action Investigation Following Delayed Release of SOND Financial Information, Contact Johnson Fistel, LLP Shareholder rights law firm Johnson Fistel, LLP is investigating whether Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND), or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Sonder securities? If you bought securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you. What is Johnson Fistel investigating? On March 15, 2024, Sonder announced it “recently identified accounting errors related to the valuation and impairment of operating lease right of use assets and related items for the fiscal years 2022

Ventyx Biosciences, Inc.

VTYX NEWS: Johnson Fistel Encourages Ventyx Biosciences Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX). The class action is on behalf of shareholders who purchased or otherwise Acquired: (a) Ventyx common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about October 21, 2021 (the “IPO” or “Offering”); and/or (b) Ventyx securities between October 21, 2021 and November 6, 2023, both dates inclusive (the “Class Period”).. Investors are hereby notified that they have until April 30, 2024, to move the Court to serve as lead plaintiff in this action. The complaint alleges that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material

Chegg, Inc.

Chegg Long-Term Shareholder Announcement: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of Chegg, Inc. (NYSE: CHGG) against certain of its officers and directors to hold them responsible for damages they allegedly caused the company to suffer. If you have continuously owned Chegg, Inc. shares since before November 1, 2021, you have certain legal rights as a shareholder.  If you want to learn more, please read below or submit your information below: Recently a class action lawsuit was filed against Chegg seeking damages, but only for those who acquired stock between May 5, 2020 to November 1, 2021 (the “Class Period”). If you purchased shares before the Class Period, you will not be able to participate in any recovery obtained in the class action, but you may be able to participate in a separate action seeking to hold the officers and directors who

Methode Electronics, Inc.

Legal Alert: Johnson Fistel has Commenced a Class Action Investigation Following Significant News Shareholder rights law firm Johnson Fistel, LLP is investigating whether Methode Electronics, Inc. (“Methode” or the “Company”) (NYSE: MEI) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Methode securities? If you bought securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On July 14, 2023, Methode announced that its Chief Operating Officer, Joseph Khoury, had been placed on leave and that his “powers, authority and duties . . . were suspended.” Then, on December

Akero Therapeutics, Inc.

Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Akero Therapeutics Shareholders Shareholder rights law firm Johnson Fistel, LLP is investigating whether Akero Therapeutics, Inc. (“Akero” or “the Company”) (NASDAQ: AKRO) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Akero securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Class Action: Johnson Fistel Encourages Amylyx Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX). The class action is on behalf of shareholders who purchased or otherwise acquired securities between November 11, 2022 to November 8, 2023, both dates inclusive (the “Class Period”). Investors are hereby notified that they have until April 9, 2024, to move the Court to serve as lead plaintiff in this action. The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) defendants had overstated RELYVRIO’s (a dual UPRBax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol, for the treatment of ALS in adults in the U.S.) commercial prospects; (ii) patients were discontinuing treatment with RELYVRIO after six months;